Related Experiment Video
Updated: May 23, 2026

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
Overweight and obesity in Jordanian adults before and after COVID-19: a multi-index comparison
Buthaina Alkhatib1, Lana M Agraib2,3, Islam Al-Shami1
1Department of Clinical Nutrition and Dietetics, Faculty of Applied Medical Sciences, The Hashemite University, Zarqa, Jordan.
Background:
The prevalence of overweight and obesity has increased globally after COVID-19, including in Jordan. This study aimed to assess the prevalence of overweight and obesity among Jordanian adults using multiple anthropometric indicators.
Methods:
A cross-sectional study was conducted among 2,633 adults aged 18-65 (1,027 males; 1,606 females). Trained nutritionists collected anthropometric and body composition measurements, including body weight, height, waist circumference (WC), body mass index (BMI), waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR) using a structured survey. Obesity was calculated using both global and Jordan-specific cut-offs.
Results:
The prevalence of overweight and obesity varied by indicator, ranging from 41.7% (WHtR using Jordan-specific cut-offs) to 72.9% (body fat percentage). BMI-defined obesity affected 70-73% of both sexes. Central obesity was more prevalent in females (46.9-73.2%) compared to males (38.8-65.3%). Females had significantly higher odds of central obesity (OR = 2.23-2.48), whereas males showed higher odds when obesity was assessed using WHR, WHtR, and body-fat measures. Trends from 2009 to 2024 indicate persistently high prevalence rates, with slight declines in BMI- and WHtR-based obesity, while central obesity remained elevated, particularly among females.
Conclusion:
Obesity remains highly prevalent among Jordanian adults, with notable sex-specific differences, especially in central adiposity. Public health interventions should target high-risk groups and incorporate multiple anthropometric indicators along with sex- specific prevention and surveillance strategies.
Related Concept Videos
Obesity
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Bias in Epidemiological Studies
Relative Risk
